Folate intake and pancreatic cancer incidence: A prospective study of swedish women and men

Journal of the National Cancer Institute

Volumn 98, Issue 6, 2006, Pages 407-413

  Larsson, Susanna C ^a   Håkansson, Niclas ^a   Giovannucci, Edward ^b,c   Wolk, Alicia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHANNING LABORATORY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RISK; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; EATING HABIT; FEMALE; FOLLOW UP; FOOD INTAKE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; SEX RATIO; SMOKING HABIT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SWEDEN; AGED; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FRUIT; INCIDENCE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PANCREAS TUMOR; PROPORTIONAL HAZARDS MODEL; RISK; SMOKING; TREATMENT OUTCOME; VEGETABLE;

ADULT; AGED; ALCOHOL DRINKING; ANTICARCINOGENIC AGENTS; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; FOOD HABITS; FRUIT; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; SWEDEN; TREATMENT OUTCOME; VEGETABLES;

EID: 33644953782     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj094     Document Type: Article

References (59)

1. Kim YI. Folate and DNA methylation: A mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004;13:511-9.
2. Choi SW, Mason JB. Folate and carcinogenesis: An integrated scheme. J Nutr 2000;130:129-32.
3. Shrubsole MJ, Jin F, Dai Q, Shu XO, Potter JD, Hebert JR, et al. Dietary folate intake and breast cancer risk: Results from the Shanghai Breast Cancer Study. Cancer Res 2001;61:7136-41.
4. Larsson SC, Giovannucci E, Wolk A. Dietary folate intake and incidence of ovarian cancer: The Swedish Mammography Cohort. J Natl Cancer Inst 2004;96:396-402.
5. Zhang S, Hunter DJ, Hankinson SE, Giovannucci EL, Rosner BA, Colditz GA, et al. A prospective study of folate intake and the risk of breast cancer. JAMA 1999;281:1632-7.
6. Negri E, La Vecchia C, Franceschi S. Re: Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000;92:1270-1.
7. Rohan TE, Jain MG, Howe GR, Miller AB. Dietary folate consumption and breast cancer risk. J Natl Cancer Inst 2000;92:266-9.
8. Voorrips LE, Goldbohm RA, Brants HA, van Poppel GA, Sturmans F, Hermus RJ, et al. A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9:357-65.
9. Nomura AM, Hankin JH, Kolonel LN, Wilkens LR, Goodman MT, Stemmermann GN. Case-control study of diet and other risk factors for gastric cancer in Hawaii (United States). Cancer Causes Control 2003;14: 547-58.
10. Mayne ST, Risch HA, Dubrow R, Chow WH, Gammon MD, Vaughan TL, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 2001;10:1055-62.
11. Pelucchi C, Talamini R, Negri E, Levi F, Conti E, Franceschi S, et al. Folate intake and risk of oral and pharyngeal cancer. Ann Oncol 2003;14: 1677-81.
12. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 2002;132(8 Suppl):2350S-2355S.
13. Larsson SC, Giovannucci E, Wolk A. A prospective study of dietary folate intake and risk of colorectal cancer: Modification by caffeine intake and cigarette smoking. Cancer Epidemiol Biomarkers Prev 2005;14:740-3.
14. Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: A meta-analytical approach. Int J Cancer 2005; 113:825-8.
15. Stolzenberg-Solomon RZ, Albanes D, Nieto FJ, Hartman TJ, Tangrea JA, Rautalahti M, et al. Pancreatic cancer risk and nutrition-related methylgroup availability indicators in male smokers. J Natl Cancer Inst 1999;91: 535-41.
16. Stolzenberg-Solomon RZ, Pietinen P, Barrett MJ, Taylor PR, Virtamo J, Albanes D. Dietary and other methyl-group availability factors and pancreatic cancer risk in a cohort of male smokers. Am J Epidemiol 2001;153: 680-7.
17. Skinner HG, Michaud DS, Giovannucci EL, Rimm EB, Stampfer MJ, Willett WC, et al. A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol 2004;160:248-58.
18. Bailey LB. Folate status assessment. J Nutr 1990;120 Suppl 11:1508-11.
19. Halsted CH, Villanueva JA, Devlin AM, Chandler CJ. Metabolic interactions of alcohol and folate. J Nutr 2002;132 (8 Suppl):2367S-2372S.
20. Hillman RS, Steinberg SE. The effects of alcohol on folate metabolism. Annu Rev Med 1982;33:345-54.
21. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994;60:559-66.
22. Bergström L, Kylberg E, Hagman U, Erikson H, Bruce Å. The food composition database KOST: The National Administration's information system for nutritive values of food. Vår Föda 1991;43:439-47.
23. Messerer M, Johansson SE, Wolk A. The validity of questionnaire-based micronutrient intake estimates is increased by including dietary supplement use in Swedish men. J Nutr 2004;134:1800-5.
24. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
25. Cox DR, Oakes D. Analysis of survival data. London (U.K.): Chapman and Hall; 1984.
26. Willett W, Stampfer MJ. Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 1986;124:17-27.
27. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
28. Greenland S, Michels KB, Robins JM, Poole C, Willett WC. Presenting statistical uncertainty in trends and dose-response relations. Am J Epidemiol 1999;149:1077-86.
29. Larsson SC, Permert J, Håkansson N, Näslund I, Bergkvist L, Wolk A. Overall obesity, abdominal adiposity, diabetes, and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005;93:1310-5.
30. Baghurst PA, McMichael AJ, Slavotinek AH, Baghurst KI, Boyle P, Walker AM. A case-control study of diet and cancer of the pancreas. Am J Epidemiol 1991;134:167-79.
31. Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, Brown LM, et al. Dietary and nutritional factors and pancreatic cancer: A case-control study based on direct interviews. J Natl Cancer Inst 1998;90: 1710-9.
32. Kim YI. Will mandatory folic acid fortification prevent or promote cancer? Am J Clin Nutr 2004;80:1123-8.
33. Kamen B. Folate and antifolate pharmacology. Semin Oncol 1997;24(5 Suppl 18):S18-30 - S18-39.
34. Food and Drug Administration. Food standards: Amendment of standards of identity for enriched grain products to require addition of folic acid. Final rule. 21 CFR Parts 136, 137, and 139. Fed Regist 1996;61: 8797-8807.
35. Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J Natl Cancer Inst 2003;95:373-80.
36. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997;94:3290-5.
37. Mason JB, Levesque T. Folate: Effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Williston Park) 1996;10:1727-36, 1742-3; discussion 1743-4.
38. Duthie SJ. Folic acid deficiency and cancer: Mechanisms of DNA instability. Br Med Bull 1999;55:578-92.
39. Chen RZ, Pettersson U, Beard C, Jackson-Grusby L, Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 1998;395: 89-93.
40. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003;63: 4158-66.
41. Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000;60:1835-9.
42. Ueki T, Toyota M, Skinner H, Walter KM, Yeo CJ, Issa JP, et al. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res 2001;61:8540-6.
43. Balaghi M, Wagner C. Methyl group metabolism in the pancreas of folate-deficient rats. J Nutr 1992;122:1391-6.
44. Yeo EJ, Wagner C. Tissue distribution of glycine N-methyltransferase, a major folate-binding protein of liver. Proc Natl Acad Sci U S A 1994;91: 210-4.
45. Elseweidy M, Singh M. Folate deficiency and pancreatic acinar cell function. Proc Soc Exp Biol Med 1984;177:247-52.
46. Hoover KL, Poirier LA. Hepatocyte-like cells within the pancreas of rats fed methyl-deficient diets. J Nutr 1986;116:1569-75.
47. Parsa I, Marsh WH, Fitzgerald PJ. Pancreas acinar cell differentiation. VI. Effects of methyl donors and homocysteine. Fed Proc 1972;31:166-75.
48. Balaghi M, Horne DW, Woodward SC, Wagner C. Pancreatic one-carbon metabolism in early folate deficiency in rats. Am J Clin Nutr 1993;58: 198-203.
49. Balaghi M, Wagner C. Folate deficiency inhibits pancreatic amylase secretion in rats. Am J Clin Nutr 1995;61:90-6.
50. Farber E, Popper H. Production of acute pancreatitis with ethionine and its prevention by methionine. Proc Soc Exp Biol Med 1950;74:838-40.
51. Goldberg RC, Chaikoff IL, Dodge AH. Destruction of pancreatic acinar tissue by DL-ethionine. Proc Soc Exp Biol Med 1950;74:869-72.
52. Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002;51: 849-52.
53. Lowenfels AB, Maisonneuve P, DiMagno EP, Elitsur Y, Gates LK Jr, Perrault J, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442-6.
54. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, et al. Pancreatitis and the risk of pancreatic cancer: International Pancreatitis Study Group. N Engl J Med 1993;328:1433-7.
55. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3.
56. Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA, et al. 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1470-6.
57. Wang L, Miao X, Tan W, Lu X, Zhao P, Zhao X, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and thymidylate synthase and risk of pancreatic cancer. Clin Gastroenterol Hepatol 2005;3: 743-51.
58. Matsubayashi H, Skinner HG, Iacobuzio-Donahue C, Abe T, Sato N, Riall TS, et al. Pancreaticobiliary cancers with defi cient methylenetetrahydrofolate reductase genotypes. Clin Gastroenterol Hepatol 2005;3:752-60.
59. Lowenfels AB, Maisonneuve P. Pancreatic cancer: Development of a unifying etiologic concept. Ann N Y Acad Sci 1999;880:191-200.